Perrigo (PRGO) Change in Acquisitions & Divestments (2015 - 2017)
Perrigo's (PRGO) quarterly Change in Acquisitions & Divestments came in at $2.2 billion in Q3 2017, up 2802.7% on a QoQ basis from -$81.4 million in Q2 2015.
Perrigo (PRGO) Change in Acquisitions & Divestments (2015 - 2017) Analysis & Trends
Perrigo (PRGO) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $2.2 billion in Q3 2017.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $2.2 billion in Q3 2017; TTM through Dec 2018 was $2.2 billion, a 3.84% increase from a year earlier, with the FY2017 full-year figure at $2.2 billion, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q3 2017 stood at $2.2 billion, up from -$81.4 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for PRGO reached as high as $2.2 billion in Q3 2017 and fell as low as -$81.4 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Perrigo | 1.44 Bn | 1.08 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 2.20 Bn |
| Sep 30, 2017 | 2.20 Bn |
| Jun 27, 2015 | -81.40 Mn |
| Jun 27, 2015 | -81.40 Mn |